S-(-)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthalene, 97.0%, 25g

ETHYL TRANS-3-(-2-FLUOROCYCLOPROPYL)-3-OXOPROPANOATE, 95.0%, 250mg

2-(1H-Pyrazol-4-yl)quinoxaline, 95.0%, 5g

Methyl DL-2-isothiocyanatobutyrate, 98.0%, 5g

2-Phenyl-3-pyrrolidin-1-yl-propan-1-ol, 97.0%, 1g

N-[2,6-BIS(1-METHYLETHYL)PHENYL]-N'-[4-[(4-NITROPHENYL)THIO]PHENYL]UREA, 98%, 5mg

5-Bromo-4-chloropyridin-3-amine, 95.0%, 1g

2,4-DINITROBENZENESULFONIC ACID SODIUM SALT, 95.0%, 1g

Colonna capillare per GC ROTI®Cap-1 MS, 60 m, 0,25 mm, 0,25 µm, 1 Pezzo(i)

1-Benzyl 4-(tert-butyl) (2R,5R)-2-(hydroxymethyl)-5-methylpiperazine-1,4-dicarboxylate, 98%, 1g

5-Nitroisoindoline-1,3-dione, 97.0%, 1kg

2-(2,6-Dioxo-piperidin-3-yl)-4-fluoroisoindoline-1,3-dione, 98.0%, 1g

4,6-Dichloro-1H-pyrazolo[3,4-d]pyrimidine, 97.0%, 5g